International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

PostScription: Opportunities to Change the Pharmacy Landscape

Author(s): Menighan Thomas E

Issue: May/Jun 2015 - Volume 19, Number 3
View All Articles in Issue

Page(s): 271

PostScription: Opportunities to Change the Pharmacy Landscape Page 1

Download in electronic PDF format for $75

Abstract:

Related Keywords: Thomas E. Menighan, BSPharm, MBS, ScD (Hon), FAPhA, American Pharmacists Association, reimbursement, pharmacist patient care services, healthcare provider, compounded drug distribution, U.S. Congress

Related Categories: LEGAL, PROFESSIONAL ISSUES

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
PostScription: Opportunities to Change the Pharmacy Landscape Menighan Thomas E	May/Jun 2015 Pg. 271
PostScription: Pharmacists Advancing Toward Provider Status Menighan Thomas E	Jan/Feb 2015 Pg. 86-87
Patient-centered Care as Value-added Service by Compounding Pharmacists McPherson Timothy B, Fontane Patrick E, Day Jonathan R	Jul/Aug 2013 Pg. 339-343
PostScription: Progress Report: Provider Status Continues to Gain Strength! Menighan Thomas E	Sep/Oct 2015 Pg. 437
PostScription: What's Your Patient Care Story? Menighan Thomas E	Mar/Apr 2015 Pg. 174-175
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Huffman DC, Holmes Erin R	Jan/Feb 2008 Pg. 74-82
PreScription: American Pharmacists Assocation and Compounding: New Partnership Reflects Old Ties Menighan Thomas E	Jan/Feb 2010 Pg. 4
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic McElhiney Linda F	Jul/Aug 2020 Pg. 287-295
PostScription: APhA2015: You Spoke, We Listened, and What a Success! Menighan Thomas E	Jul/Aug 2015 Pg. 348-349
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Allen Loyd V Jr, Williams LaVonn A	Jul/Aug 2012 Pg. 294-298
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake	Sep/Oct 2015 Pg. 377-380
Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists Huffman DC, Holmes Erin R	Nov/Dec 2006 Pg. 462-468
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter Miller David G	May/Jun 2014 Pg. 208
Patient Satisfaction with Pharmacist Intervention and Consultation in HRT DiMaggio Jennifer Lyn, Reed-Kane Dana	Jul/Aug 2003 Pg. 258-263
PostScription: Pharmacy Benefit Managers and Compounding Pharmacists: Billing for Services Lees Deril J	Jan/Feb 2014 Pg. 87
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Yoch Doug	Mar/Apr 2017 Pg. 95-102
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A	Nov/Dec 2011 Pg. 526-527
Types of Pharmacy/Pharmacists Williams LaVonn A	Jul/Aug 2013 Pg. 294-301
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
Return to Top